Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update

Go back to Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
(NASDAQ: KYMR) Delayed: 108.35 --0 (-0%)
Previous Close $108.35    52 Week High $ 
Open $108.35    52 Week Low $ 
Day High $108.35    P/E N/A 
Day Low $108.35    EPS $ 
Volume 5,169